Cycloinulo-oligosaccharides (cyclofructans [CF]) are the cyclic oligosaccharides which consist of six to eight molecules of ␤-(231)-linked D-fructofranose (CF6, CF7, and CF8). This bowl-shaped structure of CF resembles that of cyclodextrins (cyclic malto-oligosaccharides), which have been used extensively in the medical, food, and chemical fields (17). An analysis of the crystal structure of CF6 revealed that its central skeleton had the same structure as that of 18-crown-6-crown ether (6, 16). Accordingly, CF6 has the ability to form complexes with metal cations (7, 21, 23) . The practical application of CF has been widely examined, and it has been shown that CF has stabilizing effects on various materials during freezing and thawing, e.g., dough used for bread, liposomes used in the cosmetic and medical fields, and so on.
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CF is synthesized from inulin through an intramolecular transfructosylation reaction. Inulin is a polyfructan consisting of a linear ␤-(231)-linked polyfructose chain with a terminal glucose residue. The enzyme which catalyzes this transfructosylation is cycloinulo-oligosaccharide fructanotransferase (CFTase). At present, two microorganisms, Bacillus circulans OKUMZ 31B (6) and B. circulans MCI-2554 (11) , have been found to produce CFTase.
The CFTase gene from B. circulans MCI-2554 was isolated, and its nucleotide sequence was determined. In future uses of CF with drugs or foods, baker's yeast (Saccharomyces cerevisiae) is a good choice for an applicator. Because it is a eukaryote that has GRAS (generally recognized as safe) status, it is suitable for the safe production of foreign proteins (15, 18) . We have developed a novel and powerful heterologous gene expression system in S. cerevisiae using the 5Ј upstream region of the isocitrate lyase gene (UPR-ICL) from an alkanotrophic yeast, Candida tropicalis (5, 24, 25) .
Here, we report the expression of a truncated fragment of the CFTase gene of B. circulans MCI-2554 in S. cerevisiae under the control of UPR-ICL and its purification, characterization, and stable production by S. cerevisiae.
Construction of a plasmid for expression of a truncated form of the CFTase gene. A DNA fragment containing the CFTase gene was isolated from the genomic library of B. circulans MCI-2554 prepared by the standard method (19) . Sequence analysis showed that there was a long open reading frame which encoded a protein of 1,503 amino acid residues (Fig. 1A) . The overall structure of the CFTase gene showed that there were four repeat sequences, three of which were located in the N-terminal region (R1 to R3) and one of which was located near the C terminus (R4). Between these repeat sequences, there was a region whose sequence showed similarity to that of invertase (the core region). For production of recombinant CFTase in S. cerevisiae (yeast CFTase), we used a truncated fragment of the CFTase gene (⌬K2 fragment) lacking the region encoding the three N-terminal repeat sequences (residues 57 to 558). When the ⌬K2 fragment was expressed in Escherichia coli, the recombinant proteins produced had significant enzymatic activities and the CFTase activity in the culture supernatant was even higher than when the entire CFTase gene was expressed (unpublished data).
For the secretion of yeast CFTase into the culture medium, the prepro leader sequence of the ␣-factor precursor (MF␣1) was fused to the ⌬K2 fragment of the CFTase gene. The prepro secretion sequence of MF␣1 was amplified from plas-mid pLS01 by PCR with the following primers: 5Ј-AAGGAT CCGTCGACATGAGATTTCCTTCAATT-3Ј and 5Ј-TCTCT AGAATCCAAAGATACCCCTTC-3Ј. pLS01 has the 1.7-kbp EcoRI-EcoRI fragment of MF␣1 inserted at the EcoRI site of pUC13 (2) . The amplified fragment was cut with SalI and XbaI and inserted into pUC19, which has an XhoI site instead of an SmaI site. The CFTase gene was amplified from pECF21⌬ K21, which contains the ⌬K2 fragment of the CFTase gene, with the following primers: 5Ј-CGGAATCTCGTCTAGAGC CGAACCCG-3Ј and 5Ј-CGAGTCGAGACTCGAGATCTA AGCTT-3Ј. The amplified fragment was cut with XbaI and XhoI and placed downstream of the ␣-factor prepro secretion sequence. The XbaI site located between the ␣-factor prosequence and the CFTase gene corresponds to the last two amino acids of the ␣-factor prosequence. Introduction of the XbaI site changed its corresponding amino acid sequence, LysArg, to Ser-Arg, and Lys-Arg is the recognition sequence of the Kex2 protease for cleavage of the ␣-factor prosequence. Therefore, site-directed mutagenesis was performed by a PCRbased technique (4). After site-directed mutagenesis, the SalIXhoI fragment containing the ␣-factor prepro sequence and the ⌬K2 fragment of the CFTase gene was introduced into pWI3 (5) to make pWIF31 (Fig. 1B) . The expression plasmid, pWI3, has UPR-ICL as a promoter and the 3Ј noncoding region of the isocitrate lyase gene of C. tropicalis as a transcriptional terminator, along with a multicloning site between them. pWIF31 was then introduced into S. cerevisiae W303-1A (MATa ade2-1 his3-11 leu2-3,112 trp1-1 ura3-1 can1-100). Transformation of yeast was performed by the lithium acetate method (3) .
Purification of yeast CFTase. Yeast cells harboring pWIF31 were cultivated in SA medium (0.67% yeast nitrogen base without amino acids [Difco, Detroit, Mich.], 1% sodium acetate, 0.002% adenine sulfate, uracil, L-histidine-HCl, 0.003% L-leucine). Culture supernatant was ultrafiltrated by a Diaflo membrane filter (YM-10; Amicon). The concentrated enzyme solution was applied to a DEAE-Sepharose CL-6B column (Pharmacia) equilibrated with 67 mM potassium phosphate buffer (pH 6.9). The absorbed enzyme was eluted by potassium phosphate buffer with a linear gradient of 0.2 to 0.3 M NaCl. The purification data are described in Table 1 .
By sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis (12) Fig. 2A, lanes 1, 3, and 5 ). There were only slight differences in the specific activities of the three molecules, and all of the preparations showed higher specific activities than that of the native CFTase from B. circulans MCI-2554 (36.4 U/mg) (10). Yeast CFTase 2 was found to be the largest in amount, being the major product in our expression system.
The N-terminal amino acid sequence for each molecule was then determined (Fig. 2B ) with a protein sequencer (model 610A; Applied Biosystems). After SDS-PAGE, proteins to be analyzed were transferred to a sheet of ProBlott (Applied Biosystems). The N-terminal amino acid sequences of yeast CFTase 2 and yeast CFTase 3 were identical (Ala-Glu-ProGly-Ala-Asp-Ile-Glu-Asp-Ala for yeast CFTase 2 and AlaGlu-Pro-Gly-Ala-Asp-Ile for yeast CFTase 3) and also corresponded to the sequence immediately after the Kex2 protease cleavage site. On the other hand, yeast CFTase 1 had a distinct N-terminal sequence (Glu-Ala-Glu-Ser-Glu), which started 14 amino acids from the first Ala detected in yeast CFTase 2 and yeast CFTase 3.
As there are five potential N-glycosylation sites (N-X-S/T) in yeast CFTase, we treated each yeast CFTase with endoglycosidase H (endo H; New England BioLabs). After endo H treatment, decreases in the molecular masses of yeast CFTase 1 and yeast CFTase 2 were observed, while the molecular mass of yeast CFTase 3 did not change ( Fig. 2A, lanes 2, 4, and 6) . Moreover, the molecular mass of endo H-treated yeast Properties of yeast CFTase. By using purified yeast CFTase 2 protein, enzymatic properties with respect to pH and temperature were analyzed. CFTase activity was assayed as described previously (10) . One unit of enzyme activity was defined as the amount of enzyme that produced 1 mol of cycloinulohexaose (CF6) per min. Figure 3A shows the effects of pH on the activity and stability of the enzyme. The optimal pH of yeast CFTase 2 was 8.0, and over 80% of the activity was still detected after incubation for 30 min at pH 6.0 to 10.0, as happened with CFTase of B. circulans (10) . Figure 3B shows the effects of temperature on the activity and stability of the enzyme. The maximal activity was observed at 45°C, as with B. circulans CFTase. Interestingly, yeast CFTase 2 showed much higher thermostability than B. circulans CFTase. A high level of activity (62.1% of the initial activity) remained after 30 min of incubation at 70°C, while B. circulans CFTase was reported to lose its activity under these conditions (8, 10) . Even after incubation at 80 or 90°C, yeast CFTase 2 retained 53.6 or 20.6% of the initial activity, respectively. This high level of thermostability, however, was not observed for yeast CFTase 3; only 10.0% of the initial activity was observed after 30 min of incubation at 70°C. These results indicate that the N-glycosylated carbohydrate chain(s) of yeast CFTase 2 plays an important role in the thermostability of the enzyme. There have been several reports indicating that N-glycosylated enzymes produced in S. cerevisiae have increased thermostability compared to that of their unglycosylated counterparts and that removal of the N-linked carbohydrate chain(s) results in decreases in their thermostability (13, 22) .
Production of yeast CFTase with a chromosomally integrated expression system. For the stable production of yeast CFTase, we constructed an S. cerevisiae strain in which multiple copies of the CFTase gene were integrated into its chromosomes. A PvuII-PvuII fragment from pWIF31 containing UPR-ICL, the ␣-factor prepro sequence, the ⌬K2 fragment of the CFTase gene, and the 3Ј noncoding region of the ICL gene of C. tropicalis was excised and introduced into the yeast integrative vectors pRS403 and pRS404 (20) that had been digested by PvuII to construct pWIF33 and pWIF34, respectively (Fig. 4A ). pWIF33 and pWIF34 were both cut by BstXI and introduced into S. cerevisiae W303-1A to construct the CF/ HW2A strain, in which two copies of the CFTase gene were transformed. Integration of the CFTase gene was confirmed by Southern blot analysis (9) with an HIS3 or TRP1 DNA fragment as a probe (Fig. 4B) .
CF/HW2A was cultivated in a flask with YPE medium (1% yeast extract, 2% peptone, 2% [vol/vol] ethanol), and the CFTase activity in the culture supernatant was assayed periodically over 120 h. YPE medium was previously shown to highly induce UPR-ICL-mediated gene expression (25) . CFTase activity significantly increased between 24 and 48 h of cultivation and continued to increase gradually even up to 120 h of cultivation. The level of CFTase activity at this point was 391 U per liter of culture, which corresponded to 8.40 mg of CFTase protein per liter of culture (Fig. 5) . The mitotic were measured by incubating enzyme at the indicated pHs for 30 min at 37°C, and then residual activity was measured in 0.2 M phosphate buffer, pH 6.9, at 37°C. (B) Enzyme activity in 67 mM phosphate buffer, pH 6.9, (F) was measured at the indicated temperatures. Thermostability of the enzyme (E) was measured by incubating enzyme at the indicated temperatures for 30 min in 67 mM phosphate buffer, pH 6.9, and then residual activity was measured at 37°C. stability of the integrated exogenous DNA sequence after 120 h of cultivation was estimated by comparing the number of colonies grown on a nonselective plate (YPD) with that grown on a selective plate (SD). With CF/HW2A, the number of His ϩ Trp ϩ colonies on the SD plate was about 94% of that on the YPD plate. When cultivation in YPE medium was repeated five times, the number of His ϩ Trp ϩ CF/ HW2A colonies on the SD plate was still over 80% of that on the YPD plate.
Our yeast CFTase production system has several advantages for further application of this enzyme. First, as S. cerevisiae, which has the GRAS status of microorganisms, does not contain any endotoxins or lytic viruses, it is a suitable host for the production of foreign proteins to be used in pharmaceutical or food production (15, 18) . Second, compared with native B. circulans CFTase or recombinant CFTase produced by prokaryote expression systems, yeast CFTase can be produced as a glycoprotein, making yeast CFTase a highly thermostable enzyme. This high thermostability is a beneficial property for enzymes used in industry (14) . Third, our safe culture medium containing high levels of yeast CFTase can directly be used for the production of CF without purification of the enzyme, because yeast CFTase, like B. circulans CFTase, was efficiently secreted into the culture medium. Moreover, production of CFTase can readily be increased by optimizing fermentation conditions; when S. cerevisiae is cultivated under optimized conditions, cell densities of 50 to 100 mg of dry cells per ml of culture can be obtained (1) . Fourth, S. cerevisiae secretes invertase into the culture medium, which helps to hydrolyze sucrose generated from inulin during the enzyme reaction. This process prevents an increase in the concentration of sucrose in the reaction medium, which would otherwise result in high viscosity of the solution and create problems in the purification of CF.
Nucleotide sequence accession number. The nucleotide sequence of the CFTase gene from B. circulans MCI-2554 was submitted to the GenBank, EMBL, and DDBJ data banks under accession no. D87672. 
